As Regeneron and Bayer fend off competition for Eylea copycats in the courts, Sa...
Abrysvo was found to be safe in immunocompromised adults at risk for developing ...
Seizures in a patient with KIF1A-associated neurological disorder (KAND) fell fr...
Leap Consulting Group has launched a practice aimed at guiding Clinical Laborato...
The company plans to ask the US FDA to reconsider its request for an additional ...
IASO Biotherapeutics has secured the US Food and Drug Administration (FDA) appro...
Momentum Biotechnologies has partnered with Cube Biotech for supporting clients ...
Recursion has signed an agreement to merge with Exscientia to create a global te...
For an upfront payment of $700m, MSD will gain access to the CD3 and CD19-target...
Eladynos is a synthetic peptide analogue of parathyroid hormone-related protein ...
Days after competitor Novo Nordisk posted underwhelming Wegovy sales, Eli Lilly ...
The company stock was down by over 22.7% in premarket trading as AN2 shared tria...
TCR therapies are minimally engineered and can target both cell surface antigens...
Gilead Sciences has reported net income attributable to the company at $1.61bn, ...
Global contract research, development and manufacturing organisation (CRDMO) WuX...
In the past few years, there has been a significant increase in the use of GLP-1...
